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A genome-wide view of sequence mutability in mice is still limited, although biologists usually assume the same scenario for mice as for
humans. In this study, we examined the sequence context in the local environment of 482,528 mouse single nucleotide polymorphisms (SNPs).
We found that CpG-containing short sequences, in general, had more representation in the local sequences of SNPs compared to the genome
sequences. The extent of this overrepresentation was stronger in mice than in humans, which is inconsistent with previous observations of the
weaker neighboring-nucleotide biases on mouse SNPs. To exclude the CpG effect, we compared the distribution patterns of short sequences
among the six categories of SNPs. The results revealed an even stronger pattern in the CpG-containing group for C/G substitution compared to for
A/G or C/T substitutions. We next performed the first genome-wide sequence context analysis of SNPs in the mouse CpG islands. SNPs occurring
at CpG sites were 3.14-fold less prevalent than expected, suggesting the suppression of methylation-dependent deamination in the CpG islands.
The extent of this suppression was less in mice than in humans. Finally, compared with humans, the observations of a greater deficit of CpG
dinucleotides, a stronger overrepresentation of CpG-containing n-mers surrounding the polymorphic sites, and a higher SNP/genome ratio of CpG
dinucleotides in the mouse genome support the ‘‘loss of CpG islands’’ model in the mouse lineage.
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context surrounding the nucleotide polymorphisms in the
mammalian genome is important for understanding the
mechanism of point mutations, protein–DNA interactions,
and genome sequence evolution. The nonrandom fashion of
mutations was initially observed with the strong excess of
transition over transversion from the limited sequence data
from pseudogenes and functional regions [1,2]. The approxi-
mate 2:1 ratio of transitional over transversional substitution,
which has been widely observed in mammalian genomes, can
be attributed mainly to the ¨10-to 50-fold higher mutation rate
of mC to T than other transitional changes [3,4]. This0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: zzhao@vcu.edu (Z. Zhao).mechanism, which is commonly known as the CpG effect,
should result in an uneven distribution of nucleotides at the
neighboring sites of polymorphisms during evolution. Indeed,
strong neighboring-nucleotides biases, in particular strong
positive biases of nucleotide G at the 3V immediate adjacent
site and C at the 5V immediate adjacent site, were observed
among 7271 human coding single nucleotide polymorphisms
(SNPs), 2.6 million human SNPs, and 0.4 million mouse SNPs
[5–7]. However, the extent of the biases was notably less in
mice than in humans, calling for further investigation [7].
The genome-wide analyses above [5–7] were based mainly
on the examination of nucleotide compositions at each flanking
site of SNPs. Although this simple approach could easily detect
the biases at the neighboring sites, in particular at the
immediate adjacent sites, the information discovered at each
neighboring site was isolated and, thus, limited. Analysis of
short sequences surrounding the polymorphic sites would be a06) 68 – 74
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Z. Zhao, F. Zhang / Genomics 87 (2006) 68–74 69better approach than the site-by-site analysis of SNPs. This is
because (1) numerous studies suggest that the short sequence
plays a pervasive role in biological processes such as sponta-
neous mutations and control of gene expression (e.g., [8,9]) and
(2) short sequence analysis is an essential part of a variety of
applications, including motif finding, gene prediction, and even
microarray design (e.g., [10,11]). For example, Bina et al. found
that the highly ranked short sequences (9-mers) in human
proximal promoters had characteristics of the sequences in CpG
islands [8]. Therefore, a comparative analysis of short sequences
surrounding the polymorphic sites may reveal not only the
specific sequence environment that favors point mutation
occurrence and survival but also the characteristics with respect
to the polymorphism in the genomic categories (e.g., promoter
regions, exonic regions, splicing sites). Recently, Tomso and
Bell [12] investigated the distribution of the 6-mers at 1.9million
human polymorphic sites versus their flanking sequences and
revealed abundant biological information. For example, the
fragments containing CpG dinucleotides were overrepresented
at the polymorphic sites in the overall human genome. To our
knowledge, no such studies have been performed in themouse or
other mammalian genomes.
Another limitation in the previous neighboring-nucleotide
studies [6,7] is the lack of analysis of the SNPs in the categorized
genomic regions such as promoters and exons. Such information
is more important because (1) mutational effects rely on
sequence characteristics (e.g., GC content, methylation of CpG
dinucleotides) among genomic categories, (2) coding regions are
generally under selection pressure while noncoding regions in
general are not, and (3) the information in the functional regions
may be further applied to disease studies. In this study, we were
particularly interested in the SNP analysis of mouse CpG
islands, which are clusters of CpG dinucleotides in the GC-rich
regions [13]. The reasons are given below.
First, CpG dinucleotides in the mouse CpG islands are often
unmethylated. The CpG effect would generally not influence
the nucleotide changes in the islands. In addition, CpG islands
reside in approximately 60% of the promoters in the mouse
genome and may participate in the regulation of gene
expression and cell differentiation by the methylation mecha-
nism [13,14]. This suggests possible functional constraints in
the CpG island sequences [15]. How these factors influence the
genetic polymorphisms in the overall mouse genome is unclear.
Second, although the number of genes seems to be almost the
same in the mouse and human genomes, many fewer CpG
islands have been identified in mice [16,17]. For example, an
initial analysis found ¨15,500 and ¨27,000 in the nonrepe-
titive portions of the mouse and human genome sequences
[16]. The evolutionary forces causing such a large difference
between these two lineages remain largely unknown. One
explanation was the smaller fraction of extremely high GC
content in the mouse genome [16]. Obviously, this observation
itself needs to be further investigated. The second explanation
was based on a ‘‘loss of CpG islands’’ model in the mouse
genome [17]. Under this model, CpG dinucleotides in some
islands became de novo methylated. Because of the hypermu-
tability of methylated CpG dinucleotides, their GC contentdecreased and this finally led to non-CpG island sequences.
This model was supported by an examination of the mutation
patterns in three genes [17] and later at least in another gene,
Dmahp [18]. However, according to this model, the GC content
in the mouse genome would become lower. This is not true
because the GC content in the mouse genome is slightly higher
than that in the human genome [16]. To explore how the CpG
islands have evolved since the split of the human and mouse
lineages, a genome-wide comparative analysis of sequence
context patterns for nucleotide variations in the mouse and
human CpG islands is warranted.
In this study, we report an investigation into the sequence
context of 482,528 mouse SNPs, representing the largest
publicly available SNP data (dbSNP build 123). First, an
analysis of short sequences surrounding SNPs revealed that the
CpG-containing n-mers were abundantly represented in the
local environment of polymorphic sites. Second, aiming to
distinguish the CpG effect, we examined the distribution of
short sequences for each of the six categories of substitution.
We next screened the CpG islands in the mouse genome and
mapped SNPs to these putative islands. Finally, we examined
the mutational patterns and explored the CpG island mainte-
nance mechanisms in the mouse genome by comparing the
distribution of sequence context in the mouse CpG islands,
their SNPs, and the whole genome. This study provides
detailed information on the influences of local sequences on
polymorphisms and evidence supporting the loss of CpG
islands model in the mouse genome.
Results
Distribution of short sequences
A total of 482,528 mouse SNPs that were non-insertion/
deletion, were biallelic, and had a unique hit in the mouse
genome reference sequences were extracted from the down-
loaded data (dbSNP build 123). To investigate the sequence
preference of SNPs in the mouse genome, we compared the
distribution of the short fragments (n-mers, n = 3–8) in the
local sequences of these SNPs with that in the mouse genome
reference sequences. For an n-mer analysis, the local sequence
of each SNP was defined by 2  n  1 nucleotides
symmetrically overlapping the polymorphic site (see Materials
and methods). Here, we present the results of the 6-mer
analysis first. Fig. 1 displays the distribution of all possible
4096 (46) 6-mers plotted by the frequency observed in the SNP
local sequences versus the frequency in the mouse genome
sequences. Under a simple random mutation model, each
fragment in the SNP local sequences is expected to occur with
the same frequency as that in the genome sequences. Therefore,
the n-mer fragments should scatter along the diagonal line. Fig.
1 shows an overall downward skewed distribution. This was
largely attributable to those n-mers that were highly frequently
observed in the mouse genome. A further examination found
that the GC content among those 6-mer fragments with high
frequency was generally lower than among those with low
frequency. For example, the GC content among the top 10%
Fig. 1. Distribution of the 6-mers in the SNP local sequences versus the mouse
genome sequences.
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compared with 67.9% among the top 10% least frequently
observed 6-mers. The distribution above indicates that the AT-
rich short sequences in general have less representation of
nucleotide polymorphisms relative to their average in the
mouse genome.
Next, we divided all the 6-mers into two exclusive groups:
(1) the CpG group, which included 6-mers containing at least
one CpG dinucleotide (labeled red in Fig. 1), and (2) the non-
CpG group, which included the remaining 6-mers (labeled blue
in Fig. 1). The distributions of these two groups were clearly
distinct. Using a simple linear regression model, the distribu-
tion of 6-mers was represented by fSNP = 1.4  105 +
2.71fgenome (R
2 = 0.87) for the CpG group and fSNP = 9.6 
105 + 0.62fgenome (R
2 = 0.88) for the non-CpG group. Here,
fSNP and fgenome denote the frequency of a 6-mer in the SNP
local sequences and in the genome sequences, respectively.
The distribution patterns in the 6-mer analysis were
similarly observed in other n-mer analyses; however, the
extent of difference between CpG and non-CpG groups varied.
Table 1 summarizes the linear regression for each n-mer
analysis. As in humans [19], we observed a trend for the slope
values in the CpG group to become larger when n was
smaller. However, for each n-mer analysis, the slope value inTable 1
Linear regression for n-mer fragments
Size (n-mer) CpG group
Intercept (a) Slope (h) R2 p
3 –4.5  10– 3 7.33 0.80 0.0
4 1.4  10– 4 3.88 0.81 <0.0
5 4.7  10– 5 3.18 0.87 <0.0
6 1.4  10– 5 2.71 0.87 <0.0
7 4.5  10– 6 2.31 0.83 <0.0
8 1.7  10– 6 1.84 0.72 <0.0
The CpG group includes the fragments containing at least one CpG dinucleotide (lab
dinucleotide (labeled blue in Fig. 1). The linear regression for these two groups is ex
each n-mer observed in the SNP local sequences and in the genome sequences.the CpG group was consistently larger in mice than in
humans; this difference was conversely observed in the non-
CpG group. For example, in the CpG group, the slope value in
4-mer analysis was 3.88 in mice and 2.61 in humans. Note
that the slope values in the non-CpG group were within a
more limited range (0.45 to 0.62) in mice than in humans
(0.48 to 0.92).
Short sequence analysis by SNP categories
The above distribution patterns in the CpG group reflected
the CpG effect in the mouse genome. Since the hypermuta-
bility of CpG in the mouse genome does not affect the
transversional substitutions (i.e., A/C, G/T, A/T, and C/G), we
examined the distribution of n-mers for each category of
SNPs. The distribution of the 6-mers, plotted by the frequency
in the local sequences of each SNP category versus the mouse
genome sequences, is displayed in Supplementary Fig. S1. As
expected, the distribution patterns for the categories A/G and
C/T, as well as A/C and G/T, were essentially the same
because of the symmetric base-pair characteristics of DNA.
However, the distribution patterns among the others were
remarkably different. Table 2 summarizes the linear regression
for the 6-mers in the CpG group and the non-CpG group for
each SNP category. In the CpG group, the slope value was the
highest for category C/G (3.66) and the lowest (0.54) for
category A/T. This sharp difference was conversely observed
in the non-CpG group (i.e., the slope value was 0.52 and 1.65,
respectively). Surprisingly, in the CpG group, the slope value
for category C/G was even larger than that for category A/G or
C/T (Table 2). This difference was not observed in the analysis
of human SNPs [19]. In humans, the slope value in the CpG
group was 2.36 for category C/G, less than that (2.55) for
category A/G or C/T. Moreover, the slope values for
categories A/C and G/T were close to 2 in the CpG group;
this is nearly twice that (1.06) observed in humans. The
difference among the six SNP categories in the 6-mer analysis
was similarly observed in other n-mer analysis; with a trend
toward a larger difference among the six categories when n
became smaller. For example, in the CpG group of the
tetramers, the slope value was 5.65 for category C/G, nearly
eight times that (0.71) compared to category A/T (Supple-
mentary Table S1).Non-CpG group
Intercept (a) Slope (h) R2 p
026 8.3  10– 3 0.45 0.75 <0.0001
001 1.7  10– 3 0.56 0.86 <0.0001
001 3.7  10– 4 0.61 0.89 <0.0001
001 9.6  10– 5 0.62 0.88 <0.0001
001 2.8  10– 5 0.59 0.84 <0.0001
001 8.9  10– 6 0.52 0.79 <0.0001
eled red in Fig. 1) and non-CpG group includes the fragments without any CpG
pressed by fSNP = a + h fgenome, where fSNP and fgenome denote the frequency of
Table 2
Linear regression for 6-mers by SNP category
Category CpG group Non-CpG group
Intercept (a) Slope (h) R2 p Intercept (a) Slope (h) R2 p
A/G 1.1  10– 5 3.10 0.75 <0.0001 8.4  10– 5 0.67 0.31 <0.0001
C/T 1.3  10– 5 3.06 0.74 <0.0001 8.3  10– 5 0.68 0.31 <0.0001
A/C 2.4  10– 5 1.95 0.42 <0.0001 2.8  10– 5 0.88 0.30 <0.0001
G/T 2.6  10– 5 1.91 0.42 <0.0001 2.8  10– 5 0.87 0.30 <0.0001
A/T 4.3  10– 6 0.54 0.28 <0.0001 –2.1  10– 4 1.65 0.35 <0.0001
C/G 1.9  10– 5 3.66 0.63 <0.0001 1.2  10– 4 0.52 0.20 <0.0001
The CpG group includes the fragments containing at least one CpG dinucleotide (labeled in red in Fig. S1) and non-CpG group includes the fragments without any
CpG dinucleotide (labeled in blue in Fig. S1). The linear regression for these two groups is expressed by fSNP = a + h fgenome, where fSNP and fgenome denote the
frequency of each n-mer observed in the SNP local sequences and in the genome sequences.
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A total of 20,713 CpG islands were identified, with an
average length of 1034 bp. The average GC content for the
CpG island sequences was 60.46%; this compared with
41.55% in the non-CpG island sequences and 41.71% in the
whole genome sequences we used. The average ObsCpG/
ExpCpG ratio was 0.74 in the CpG island sequences, 3.9 times
that (0.19) in the mouse genome sequences.
Table 3 shows the proportion of the predicted CpG island
sequences, measured by single nucleotides, CpG dinucleotides,
and CpG SNPs, on each chromosome and in the mouse genome.
The CpG SNPs included six possible nucleotides changes at the
CpG site, i.e., [A/C]G, [C/G]G, [C/T]G, C[A/G], C[C/G], and
C[G/T]. We found 111,777 CpG SNPs in the mouse genome;Table 3
Proportions of nucleotides, CpG dinucleotides, and CpG SNPs from CpG











1 41.07 0.63 5.71 1.78
2 42.06 0.96 7.75 2.17
3 40.42 0.65 5.87 1.37
4 42.20 1.00 7.99 2.67
5 42.48 0.98 7.51 2.19
6 41.37 0.70 5.98 1.74
7 43.16 1.11 8.48 3.16
8 42.30 0.93 7.16 2.80
9 42.68 0.90 7.02 2.28
10 41.33 0.81 6.48 2.82
11 43.82 1.43 10.04 3.04
12 41.55 0.75 6.49 1.76
13 41.58 0.72 5.89 2.67
14 41.01 0.64 5.61 1.51
15 41.91 0.90 7.19 2.96
16 40.86 0.67 5.71 1.16
17 42.65 1.07 8.05 4.14
18 41.38 0.75 6.17 3.16
19 42.76 1.21 8.79 2.61
X 39.20 0.50 5.43 2.01
Genome 41.71 0.85 7.00 2.23
The proportion was calculated by the observed numbers in the CpG islands
over the numbers in the corresponding chromosome or genome sequences.
CpG SNPs includes six possible nucleotide changes.
a In this category, the proportion on a chromosome was significantly
correlated with the GC content of that chromosome (p < 0.01).among them, 2498 were in the CpG islands. On average, CpG
island sequences accounted for only 0.85% of the mouse geno-
me, less than the 1.45% in the human genome [19]. However, in
contrast to the small proportion of the CpG island sequences in
the mouse genome, the CpG dinucleotides within the CpG
islands accounted for 7.00% of the total CpG dinucleotides in the
mouse genome. Finally, approximately 2.23% of themouse CpG
SNPs occurred in the CpG islands. This proportion is
remarkably lower than the proportion of CpG dinucleotides,
but higher than the proportion of CpG island sequences in the
mouse genome. Assuming that nucleotide changes occur
randomly in a sequence, SNPs were underrepresented by
approximately 3.14-fold at CpG sites in the CpG islands. The
ratio was less than that (i.e., 3.92) in the human genome.
We next compared the proportion of each type of CpG SNP.
In the CpG islands, the proportion of substitution [C/T]G and
C[A/G] was 56.10 and 52.78%, respectively (Supplementary
Table S2). This is significantly ( p  0, m2 test) lower than the
corresponding values (78.24 and 78.37%) in the non-CpG
island sequences. Since the proportion of substitution [C/T]G
(C[A/G] on other DNA strand) in the non-CpG island
sequences reflects the overall CpG effect in the mouse genome,
the significantly lower proportion in the CpG islands indicated
a strong suppression of the mCpG Y TpG mutations in mouse
CpG islands.
Distribution of dinucleotides
We examined the distribution of the 16 possible dinucleotides
in the mouse: (1) in the genome sequences, (2) in CpG island
sequences, and (3) at the SNP sites. The proportion of each
dinucleotide varied among these three categories (Table 4). The
proportion of CG dinucleotides in the mouse genome sequences
was 0.83%, the lowest among all 16 dinucleotides. In contrast,
the proportion of CG dinucleotides was 6.89% in the CpG
islands and 6.00% at the SNP sites. In the CpG island sequences,
the proportion of the dinucleotide CGwas lower than that of CC,
GG, or GC, although, as expected, all four dinucleotides had
high frequency in the CpG islands (Table 4). The range of the
proportion values among the 16 dinucleotides at the SNP sites
was much smaller than that in the genome sequences or in the
CpG island sequences. This pattern was further shown by the
ratio of the observed and expected proportion of each
dinucleotide. The ratio was only 0.19 for the CpG dinucleotide
Table 4
Dinucleotides in the mouse genome




Genome CpG islands SNP siteb Genome CpG islands SNP site
AA 9.10 4.63 6.79 8.49 1.07 0.55 0.80 0.75
AC 5.33 4.82 6.62 6.07 0.88 0.79 1.09 1.24
AG 7.34 7.19 6.26 6.08 1.21 1.18 1.03 0.85
AT 7.37 2.88 7.66 8.50 0.87 0.34 0.90 1.04
CA 7.45 6.22 6.52 6.07 1.23 1.02 1.07 0.88
CC 5.22 10.06 5.48 4.35 1.20 2.31 1.26 1.05
CG 0.83 6.89 6.00 4.35 0.19 1.58 1.38 7.23
CT 7.34 7.22 6.25 6.08 1.21 1.19 1.03 0.85
GA 6.20 6.10 5.70 6.08 1.02 1.00 0.94 0.92
GC 4.09 9.43 5.34 4.35 0.94 2.17 1.23 1.31
GG 5.22 10.06 5.45 4.35 1.20 2.31 1.25 1.04
GT 5.33 4.83 6.58 6.08 0.88 0.79 1.08 1.23
TA 6.38 2.57 6.31 8.50 0.75 0.30 0.74 0.99
TC 6.21 6.08 5.73 6.08 1.02 1.00 0.94 0.92
TG 7.46 6.28 6.52 6.08 1.23 1.03 1.07 0.87
TT 9.12 4.74 6.78 8.50 1.07 0.56 0.80 0.74
a The expected frequency of a dinucleotide fij was calculated by fi  fj, where fi and fj were the frequencies of nucleotides i and j in the mouse genome sequences.
b For each SNP, the two immediate adjacent sites were included to calculate the frequency of dinucleotides.
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genome. The ratio of CpG dinucleotide at the SNP sites over
genome sequences was 7.23, which indicated a strong bias for
CpG dinucleotides at the polymorphic sites relative to the
genome sequences.
Discussion
At present, the knowledge of the sequence mutability in the
mouse genome is still very limited; despite this, biologists
usually assume the same scenario for mice as humans. Our
previous study of 0.4 million mouse SNPs first revealed that
the extent of the biases at the two adjacent sites was notably
less in mice than in humans [7]. In this study, we have further
examined the sequence context of the mouse in the local
environment of SNPs, CpG islands, and whole genome
sequences. We analyzed 482,528 mouse SNPs, which repre-
sented the largest publicly available data set so far. Two distinct
groups were observed for all n-mer (n = 3–8) analyses: (1) the
short sequences in the CpG group were observed more
frequently in the local sequences surrounding the polymorphic
sites than in the genome sequences, while (2) the short
sequences in the non-CpG group were observed less frequently
in the sequences surrounding the polymorphic sites. This
pattern, which was similarly observed in the human genome,
reflected the strong CpG effect in the mammalian genome. To
exclude the CpG effect, we further examined the six categories
of SNPs. The results revealed that short DNA fragments in the
CpG group were even more abundant in the local sequences of
C/G compared to the A/G or C/T substitutions, while the
opposite pattern was observed for the A/T substitution. This
new finding suggests a strong preference of the sequence
environment by the different categories of substitution. Further
comparison of those top-ranking over-or underrepresented
short sequences in the local environment of SNPs with other
characteristic sequences (e.g., motifs, protein binding sites,splicing sites) may provide more insights on mutational
mechanisms, natural selection, and function.
We performed the first genome-wide sequence context
analysis of the genetic polymorphisms in the mouse CpG
islands. The results revealed that CpG dinucleotides, which
presented only ¨19% of the expected in the mouse genome,
were approximately 7.23-fold more abundant at the poly-
morphic sites than in the whole genome. On the other hand,
SNPs occurring at CpG sites were 3.14-fold less prevalent than
what was expected in the CpG islands. These detailed results in
mice extended the previous views of the hypermutability of
methylated CpG dinucleotides in the non-CpG island sequences
in the human genome and the suppression of the polymorphisms
at CpG dinucleotides in the CpG islands [6,7,12,14].
While it is not surprising to observe similar sequence context
patterns in the mouse and human genomes, some major
differences existed. Considering the large size of the data
analyzed, these differences may have important implications for
mammalian genome sequence evolution. First, the slope values
in the CpG group using the mouse data were notably larger than
those in humans. For example, in the tetramer analysis, the slope
value was 3.88 in mice and 2.61 in humans [19]. Second, for all
six categories of SNPs, the slope values for the CpG group in
mice were greater than those in humans; conversely, the slope
values for the non-CpG group in mice were generally smaller
than those in humans. Third, it appears that the distribution of the
CpG group was separated more from that of the non-CpG group
in the mouse analysis. This was observed for all SNPs and each
category of SNPs. The three points above suggests that CpG-
containing sequences in the mouse genome have more repre-
sentation of polymorphisms. This seems to suggest further a
stronger CpG effect in mice than in humans. However, this
inference is inconsistent with our previous neighboring-nucle-
otide bias analysis [7], in which we found that the extent of the
biases for nucleotide G at the 3V immediate adjacent site in mice
was much less than that in humans. The reasons for these
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occurring at the CpG sites were 7.23-fold more abundant than
expected in the mouse genome; this compared with a 6.09-fold
abundance in the human gnome. Finally, CpG SNPs were 3.14-
fold less prevalent relative to the presence of CpG dinucleotides
in the CpG islands in the mouse genome; this compared with a
3.92-fold less prevalence in the human genome (or 6.84-fold in
an early analysis [12]). The difference, though moderate,
suggests that the extent of the suppression of methylation-
dependent deamination in the mouse CpG islands may be less
than that in the human genome.
The comparative results above consistently support the
previous inference of a loss of ancestral CpG islands in the
mouse lineage [17]. Under this model, CpG dinucleotides in
some islands became de novo methylated in the mouse germ
line. Because the mutation rate of mCpGY TpG was estimated
at ¨10-to 50-fold higher than other transitions [3], it resulted in
a greater deficit of CpG dinucleotides in the mouse genome
(0.19) than in the human genome (0.24), more representation of
n-mers in the CpG group in the local sequences of SNPs, and a
higher SNP/genome ratio of CpG dinucleotide (7.23 in mice
versus 6.09 in humans, Table 4). So, why is the GC content in
today_s mouse genome higher than that in the human genome?
One possible explanation is that the CpG effect in the human
non-CpG island sequences was stronger than in the mouse non-
CpG island sequences, which is supported by our previous
analysis [7]. This finally led to a lower GC content in the
human genome. Readers may need to be cautious of these
interpretations. More detailed analysis of mutation patterns
(e.g., CG Y TG/CA) in the CpG islands located in the
orthologous regions would provide more evidence.
There are a few limitations in this study. First, because the
direction of a substitution is generally unknown for the dbSNP
data, we could not distinguish the patterns for the CY T (GY
A) substitution from those of other substitutions. Second, we
assumed an equal allele frequency for each SNP, that is, we
separated two alleles evenly when we analyzed the n-mers in
the SNP local sequences. We expect this had a minor effect in
our study because the average chromosomes used for the
mouse SNP discovery is ¨2.6 (Mouse Phenome Database,
http://www.jax.org/phenome/). The effect may be examined
indirectly by using the human SNP data generated in the
HapMap project [20]. Third, the distribution of the sequence
context in the CpG islands relies on an accurate identification
of CpG islands in the mouse genome. Although there is still a
lack of a standard definition of a CpG island, Takai and Jones_
algorithm can effectively exclude the universal Alu repeats in
the genome and identify the CpG islands that are more likely to
be associated with the 5V regions of genes [14]. This algorithm
has been applied to the NCBI database [21]; therefore, we also
used the algorithm to screen the CpG islands in this study.
Finally, the number of SNPs we used is much smaller than that
of human SNPs. It is possible that the distribution of the n-mers
(e.g., slope values) may be slightly different, although the
overall patterns are expected to be the same.
In conclusion, these analyses provide a detailed view of
the sequence context patterns observed in the local environ-ment of SNPs, CpG islands, and whole genome sequences in
mice. First, in the local environment of SNPs, we found that
the extent of the overrepresentation of CpG-containing short
sequences in the local environment of polymorphisms in the
mouse genome was stronger than that in the human genome.
Second, a further examination of sequence context among the
six categories of substitution uncovered greatly varied
distribution patterns, indicating the strong preference of the
local sequence environment by each substitution category.
Third, in the CpG islands, we found that SNPs occurring at
CpG sites were 3.14-fold less prevalent than expected,
suggesting the suppression of the polymorphisms at CpG
dinucleotides in the CpG islands. However, the extent of the
suppression in the mouse CpG islands was less than that in
humans. Finally, some evidence, such as stronger overrepre-
sentation of CpG-containing short sequences in the local
environment of SNPs in mice than in humans, appeared to
support the loss of CpG islands model in the mouse lineage.
Materials and methods
Mouse SNP and sequence data
We downloaded the mouse SNP data in XML format from ftp://
ftp.ncbi.nih.gov/snp/ on November 13, 2004 (build 123, released on November
3, 2004). A total of 581,577 reference SNPs were available across the mouse
genome; among them, 92.0% were validated. The mouse genome sequence
build 33 was released in June 2004. We downloaded the contig sequences in the
mouse genome from http://genome.ucsc.edu/ on October 15, 2004.
A Perl script was developed to parse the annotation information in the
dbSNP XML files. Only those SNPs that satisfied the following criteria were
selected: (1) non-insertion/deletion, (2) biallelic, (3) having a unique hit to the
genome reference sequences, and (4) having a minimum of 7 nucleotides in
each flanking sequence of a SNP. This resulted in 482,528 SNPs that we used
for further analysis. For each SNP, we extracted the following annotation
information from XML data files: (1) alleles (e.g., A/G), (2) 5V and 3V flanking
sequences, (3) chromosome information, (4) contig ID, and (5) contig location.
Identification of CpG islands and their SNPs
Identification of the CpG islands was carried out using the CpG island
searcher program (CpGi130, http://cpgislands.usc.edu/) [22]. The CpGi130
software implemented Takai and Jones_ algorithms [14] for identifying CpG
islands from genomic sequences without filtering the repeats. We used stringent
search criteria of GC content55%, ObsCpG/ExpCpG0.65, and length500 bp
to screen CpG islands in the mouse genome sequences. The algorithm based on
the criteria above can effectively exclude the Alu repeats, which typically have a
sequence length of 300 bp, GC content of 53%, and ObsCpG/ExpCpG ratio of 0.62
[23].
We next identified the SNPs that locate in the CpG islands by comparing the
SNP locations in the contig sequences with the position index of the CpG islands.
To do that, we first examined if annotations of contig position in the dbSNP
database matched the version of the genome reference sequences. We randomly
chose 1000 SNPs across the genome. The flanking sequences of these SNPswere
used to perform a BLAST search over the genome reference sequences.
According to the search results, we found that all SNPs matched the annotation
information. A total of 6457 SNPs were then identified in the CpG islands.
Short sequence analysis in the genome and SNP local sequences
A program package (available upon request) was used to compute the
observed and expected frequency values for single nucleotides (i.e., A, C, G,
and T), dinucleotides (e.g., CG), and other short sequences (n-mers) in the
mouse genome, SNP flanking sequences, and CpG island sequences,
Z. Zhao, F. Zhang / Genomics 87 (2006) 68–7474respectively. This program package was written in Java and was run in a Dell
workstation in the Linux environment.
For the n-mer analysis, a modified method of Tomso and Bell [12] was used
to obtain the frequency of each n-mer surrounding the polymorphic sites and in
the mouse genome reference sequences. First, for each SNP, we extracted the
local sequence, which was defined by 2  n  1 nucleotides symmetrically
overlapping the polymorphic site. For example, in the 6-mer analysis, we
obtained 5 nucleotides from the 5V flanking sequences, 5 nucleotides from the
3V flanking sequences, and the nucleotide at the polymorphic site. Next, a
sliding window of size n was applied to count the occurrence of n-mers in the
SNP local sequences and genome sequences, respectively. The frequency of
each n-mer was calculated by the number of its counts divided by the total
number of counts of n-mers. The frequencies of n-mers were also obtained for
each category of SNPs using the above approach.
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